Us2.ai

What is Us2.ai?

Us2.ai is an FDA-cleared artificial intelligence platform that automates cardiac ultrasound analysis. It processes an echocardiogram from upload to final report and returns structured findings within seconds, with no manual frame selection or annotation.

Key capabilities of Us2.ai

• Automated measurements: guideline-based chamber quantification, diastolic function and valve evaluation
• Disease detection: heart failure, cardiac amyloidosis, aortic stenosis and pulmonary hypertension
• Strain analysis: global longitudinal strain
• Stress echocardiography: analysis of stress studies
• Automatic reports: structured report generated after analysis
• Vendor-neutral support: GE, Philips, Siemens, Canon and handheld ultrasound devices

How Us2.ai works

A study is routed to Us2.ai by DICOM from the ultrasound system or PACS, and the AI selects views and frames, measures structures and flags findings. Results flow back into PACS, CVIS and EMR systems. Cloud deployment takes days and on-premise takes weeks, and clinicians review before signing reports.

Who uses Us2.ai?

Cardiology departments, echo labs and sonographers. The vendor cites a 70% reduction in reporting time, about two extra exams per sonographer per day and 79 peer-reviewed publications.

Us2.ai pricing

Us2.ai does not publish pricing. In the US, scans bill under existing echocardiography CPT codes such as 93306, and deployment quotes come from the vendor.

Us2.ai alternatives

Ultromics offers EchoGo AI for heart failure and amyloidosis detection. Eko Health uses digital stethoscopes and ECG AI. Anumana focuses on ECG-based detection. Us2.ai automates full echo measurement and reporting.